Ilex Medical (XTAE:ILX) Total Long-Term Assets: ₪324.8 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:ILX Ilex Medical Ltd XTAE:ILX
67 GF Score
Price ₪50.19
GF Value ₪61.28
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Ilex Medical Total Long-Term Assets?

Ilex Medical XTAE:ILX -0.69% 67 Total Long-Term Assets is ₪324.8 Mil as of Jun. 2026. GuruFocus rates XTAE:ILX with a GF Score™ of 67/100 and a GF Value™ of ₪61.28 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Ilex Medical's Total Long-Term Assets for the quarter that ended in Jun. 2026 was ₪324.8 Mil.

Ilex Medical Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Ilex Medical's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ilex Medical Total Long-Term Assets Chart

Ilex Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 243.35 264.36 330.11 275.60 269.08

Ilex Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 271.89 285.72 269.08 319.32 324.78
XTAE:ILX
67GF Score
Ilex Medical Ltd XTAE:ILX
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ilex Medical Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of ₪324.8 Mil mean?
Ilex Medical (XTAE:ILX) has a Total Long-Term Assets of ₪324.8 Mil as of Jun. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Ilex Medical and its competitors.
Is Ilex Medical's Total Long-Term Assets too high?
Ilex Medical's current Total Long-Term Assets is ₪324.8 Mil. Overall, Ilex Medical has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ilex Medical's Total Long-Term Assets compare to ABT and SYK?
Ilex Medical's Total Long-Term Assets of ₪324.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Medical Devices & Instruments company?
A good Total Long-Term Assets depends on the Medical Devices & Instruments industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Ilex Medical and its competitors. Ilex Medical's current Total Long-Term Assets is ₪324.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ilex Medical stock overvalued right now?
Based on GuruFocus' analysis, Ilex Medical (XTAE:ILX) is currently considered Modestly Undervalued. The stock's GF Value™ is ₪61.28, compared to a current price of ₪50.19 — trading 18.1% below its estimated fair value. The current Total Long-Term Assets is ₪324.8 Mil. Ilex Medical's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Ilex Medical (XTAE:ILX), the current Total Long-Term Assets is ₪324.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ilex Medical (XTAE:ILX) Overvalued in 2026?

Based on GuruFocus' analysis, Ilex Medical stock appears to be undervalued. The current stock price of ₪50.19 is trading 18.1% below its estimated GF Value™ of ₪61.28. GuruFocus considers Ilex Medical to be Modestly Undervalued.

Key valuation signals for XTAE:ILX:

  • Total Long-Term Assets: ₪324.8 Mil
  • GF Value™: ₪61.28 vs. price of ₪50.19 (18.1% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the XTAE:ILX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ilex Medical Business Description

Address Kodak Building, 7 Hatnufa Street, PO Box 3156, Kiriat Arie Industrial Park, Petah Tikva, ISR, 4951025
Ilex Medical Ltd is an Israel based company engages in the marketing and distribution of diagnostic products and other medical laboratory information systems. It offers in-vitro diagnostic equipment, reagents, laboratory management software, blood bank diagnostic kits, and diagnostic support services to the healthcare sector in Israel.
67GF Score

Get the complete analysis for XTAE:ILX

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪50.19
Price
₪61.28
GF Value